{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:55:11Z","timestamp":1772121311196,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000783","name":"Research Executive Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000783","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["SB12-0088"],"award-info":[{"award-number":["SB12-0088"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011264","name":"FP7 People: Marie-Curie Actions","doi-asserted-by":"publisher","award":["607690"],"award-info":[{"award-number":["607690"]}],"id":[{"id":"10.13039\/100011264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","award":["KAW 2013.0030"],"award-info":[{"award-number":["KAW 2013.0030"]}],"id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"European Commission Seventh Framework Programme for Research and Technological Development Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004107","name":"Lars Erik Lundbergs Stiftelse f\u00f6r Forskning och Utbildning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012538","name":"Swedish Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["LUA\/ALF ALFGBG-531021"],"award-info":[{"award-number":["LUA\/ALF ALFGBG-531021"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005760","name":"G\u00f6teborgs Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mucosalimmunology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mucosal Immunology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.mucimm.2023.05.006","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T12:39:39Z","timestamp":1684154379000},"page":"486-498","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells"],"prefix":"10.1016","volume":"16","author":[{"given":"Charlotta","family":"Hansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9024-1240","authenticated-orcid":false,"given":"Cristina","family":"Lebrero-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3613-5819","authenticated-orcid":false,"given":"Karin","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5256-1972","authenticated-orcid":false,"given":"Davide","family":"Angeletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils","family":"Lycke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mucimm.2023.05.006_b0005","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/joim.12395","article-title":"Human autoimmune diseases: a comprehensive update","volume":"278","author":"Wang","year":"2015","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mucimm.2023.05.006_b0010","first-page":"571","article-title":"Oral type II collagen in the treatment of rheumatoid arthritis. A six-month double blind placebo-controlled study","volume":"18","author":"Cazzola","year":"2000","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0015","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/art.1780390413","article-title":"A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis","volume":"39","author":"Barnett","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mucimm.2023.05.006_b0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mucimm.2023.05.006_b0025","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1126\/science.8378772","article-title":"Effects of oral administration of type II collagen on rheumatoid arthritis","volume":"261","author":"Trentham","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mucimm.2023.05.006_b0030","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.4110\/in.2022.22.e9","article-title":"Targeted immunotherapy for autoimmune disease","volume":"22","author":"Jung","year":"2022","journal-title":"Immune Netw."},{"key":"10.1016\/j.mucimm.2023.05.006_b0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41551-019-0359-6","article-title":"Cancer immunotherapies repurposed for use in autoimmunity","volume":"3","author":"Boardman","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.mucimm.2023.05.006_b0040","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0045","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.3390\/ijms231911532","article-title":"The translatability of multiple sclerosis animal models for biomarkers discovery and their clinical use","volume":"23","author":"Birmpili","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mucimm.2023.05.006_b0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/nri2550","article-title":"Autoimmune T cell responses in the central nervous system","volume":"9","author":"Goverman","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0055","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1476-4598-12-98","article-title":"Cancer risk in immune-mediated inflammatory diseases (IMID)","volume":"12","author":"Beyaert","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.mucimm.2023.05.006_b0060","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mucimm.2023.05.006_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640935","article-title":"Antigen-specific immune tolerance in multiple sclerosis-promising approaches and how to bring them to patients","volume":"12","author":"Lutterotti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0070","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nm1564","article-title":"Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation","volume":"13","author":"Korn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2023.05.006_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-2249.2004.02520.x","article-title":"Oral tolerization with peptide 336\u2013351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease","volume":"137","author":"Stanford","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0080","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ene.12883","article-title":"Disease-modifying treatments for multiple sclerosis - a review of approved medications","volume":"23","author":"Torkildsen","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0085","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nature01355","article-title":"Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain","volume":"421","author":"Cua","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.mucimm.2023.05.006_b0090","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2023.05.006_b0095","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.4049\/jimmunol.161.12.6480","article-title":"IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells","volume":"161","author":"Samoilova","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.192.1.123","article-title":"Failure to suppress the expansion of the activated CD4 T cell population in interferon gamma-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis","volume":"192","author":"Chu","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.05.006_b0105","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2017.00532","article-title":"Peripherally induced regulatory T cells: recruited protectors of the central nervous system against autoimmune neuroinflammation","volume":"8","author":"Jones","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0110","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.4049\/jimmunol.169.9.4712","article-title":"Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis","volume":"169","author":"Kohm","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0115","doi-asserted-by":"crossref","first-page":"8213","DOI":"10.1073\/pnas.122224799","article-title":"Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice","volume":"99","author":"Hori","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.mucimm.2023.05.006_b0120","doi-asserted-by":"crossref","first-page":"887","DOI":"10.4049\/jimmunol.178.2.887","article-title":"Regulatory T cells maintain long-term tolerance to myelin basic protein by inducing a novel, dynamic state of T cell tolerance","volume":"178","author":"Cabbage","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0125","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.mucimm.2023.05.006_b0130","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.4049\/jimmunol.177.6.3606","article-title":"B7H1-Ig fusion protein activates the CD4+ IFN-gamma receptor+ type 1 T regulatory subset through IFN-gamma-secreting Th1 cells","volume":"177","author":"Ding","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0135","doi-asserted-by":"crossref","first-page":"e47121","DOI":"10.15252\/embr.201847121","article-title":"Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity","volume":"20","author":"Raverdeau","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.mucimm.2023.05.006_b0140","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.4049\/jimmunol.179.5.3268","article-title":"Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis","volume":"179","author":"Fitzgerald","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0145","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1038\/ni1540","article-title":"Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells","volume":"8","author":"Fitzgerald","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0150","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ni1376","article-title":"Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system","volume":"7","author":"Stumhofer","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0155","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/ni1537","article-title":"Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10","volume":"8","author":"Stumhofer","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0160","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/ni1375","article-title":"Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells","volume":"7","author":"Batten","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0165","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ni1541","article-title":"A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells","volume":"8","author":"Awasthi","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0170","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni.2695","article-title":"IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39","volume":"14","author":"Mascanfroni","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0175","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1189\/jlb.1209788","article-title":"IL-27 renders DC immunosuppressive by induction of B7\u2013H1","volume":"89","author":"Karakhanova","year":"2011","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0180","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/ni.3408","article-title":"Classical dendritic cells are required for dietary antigen-mediated induction of peripheral T(reg) cells and tolerance","volume":"17","author":"Esterh\u00e1zy","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0185","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1002\/art.24566","article-title":"Role of CTA1R7K-COL-DD as a novel therapeutic mucosal tolerance-inducing vector for treatment of collagen-induced arthritis","volume":"60","author":"Hasselberg","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.mucimm.2023.05.006_b0190","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3389\/fimmu.2017.01133","article-title":"A novel approach to reinstating tolerance in experimental autoimmune myasthenia gravis using a targeted fusion protein, mCTA1-T146","volume":"8","author":"Consonni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0195","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/pbi.12479","article-title":"Feeding transgenic plants that express a tolerogenic fusion protein effectively protects against arthritis","volume":"14","author":"Hansson","year":"2016","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.mucimm.2023.05.006_b0200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0959-4388(93)90153-P","article-title":"Experimental autoimmune encephalomyelitis as a model of immune-mediated CNS disease","volume":"3","author":"Wekerle","year":"1993","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0205","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1084\/jem.20021603","article-title":"Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis","volume":"197","author":"Bettelli","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mucimm.2023.05.006_b0210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.it.2016.04.009","article-title":"Regulation of the T cell response by CD39","volume":"37","author":"Takenaka","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0215","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ni.1912","article-title":"The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27","volume":"11","author":"Apetoh","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0220","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/eji.201343479","article-title":"IL-27 paves different roads to Tr1","volume":"43","author":"Vasanthakumar","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0225","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4049\/jimmunol.0901233","article-title":"Cutting edge: il-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells","volume":"183","author":"Pot","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0230","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.1301970","article-title":"Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response","volume":"192","author":"de Aquino","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0235","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3389\/fimmu.2016.00370","article-title":"Differential regulation of self-reactive CD4+ T cells in cervical lymph nodes and central nervous system during viral encephalomyelitis","volume":"7","author":"Savarin","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0240","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ni.2031","article-title":"The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF","volume":"12","author":"El-Behi","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0245","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12974-019-1674-2","article-title":"Molecular biomarkers in multiple sclerosis","volume":"16","author":"Ziemssen","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mucimm.2023.05.006_b0250","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.mucimm.2023.05.006_b0255","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0260","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/s41385-022-00510-1","article-title":"ADP-ribosylating adjuvant reveals plasticity in cDC1 cells that drive mucosal Th17 cell development and protection against influenza virus infection","volume":"15","author":"Arabpour","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0265","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP","volume":"37","author":"Becht","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0270","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.cell.2019.09.035","article-title":"Transcriptional basis of mouse and human dendritic cell heterogeneity","volume":"179","author":"Brown","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2023.05.006_b0275","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data","volume":"177","author":"Stuart","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.mucimm.2023.05.006_b0280","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nature11337","article-title":"T cells become licensed in the lung to enter the central nervous system","volume":"488","author":"Odoardi","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.mucimm.2023.05.006_b0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/mi.2015.45","article-title":"An IL-27\/Lag3 axis enhances Foxp3+ regulatory T cell-suppressive function and therapeutic efficacy","volume":"9","author":"Do","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0290","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.1004182","article-title":"A role for IL-27 in limiting T regulatory cell populations","volume":"187","author":"Wojno","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0295","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clim.2016.09.007","article-title":"Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction - A comparative study","volume":"173","author":"Adnan","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0300","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.1203053","article-title":"Protein kinase C inhibitor generates stable human tolerogenic dendritic cells","volume":"191","author":"Matsumoto","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0305","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1038\/s41467-022-32849-1","article-title":"Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells","volume":"13","author":"Adamik","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mucimm.2023.05.006_b0310","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.immuni.2016.11.008","article-title":"Cholesterol accumulation in CD11c+ immune cells is a causal and targetable factor in autoimmune disease","volume":"45","author":"Ito","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.mucimm.2023.05.006_b0315","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.cmet.2017.04.005","article-title":"Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity","volume":"25","author":"Westerterp","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.mucimm.2023.05.006_b0320","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1074\/jbc.M005988200","article-title":"7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor","volume":"276","author":"Savouret","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mucimm.2023.05.006_b0325","doi-asserted-by":"crossref","first-page":"9886","DOI":"10.1038\/s41598-017-06907-4","article-title":"A unique tolerizing dendritic cell phenotype induced by the synthetic triterpenoid CDDO-DFPA (RTA-408) is protective against EAE","volume":"7","author":"Wei","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mucimm.2023.05.006_b0330","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41435-021-00139-3","article-title":"Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies","volume":"22","author":"Chakraborty","year":"2021","journal-title":"Genes Immun."},{"key":"10.1016\/j.mucimm.2023.05.006_b0335","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0340","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0345","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.167.6.3398","article-title":"CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen","volume":"167","author":"Mowat","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0350","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm1197","article-title":"Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis","volume":"11","author":"Greter","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.mucimm.2023.05.006_b0355","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41385-020-0334-2","article-title":"A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection","volume":"14","author":"Bernasconi","year":"2021","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.mucimm.2023.05.006_b0360","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.mucimm.2023.05.006_b0365","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","article-title":"ClueGO: a cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks","volume":"25","author":"Bindea","year":"2009","journal-title":"Bioinformatics"}],"container-title":["Mucosal Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021923000375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933021923000375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:30:23Z","timestamp":1761831023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933021923000375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1933021923000375"],"URL":"https:\/\/doi.org\/10.1016\/j.mucimm.2023.05.006","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.11.536382","asserted-by":"object"}]},"ISSN":["1933-0219"],"issn-type":[{"value":"1933-0219","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tr1 cell-mediated protection against autoimmune disease by intranasal administration of a fusion protein targeting cDC1 cells","name":"articletitle","label":"Article Title"},{"value":"Mucosal Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mucimm.2023.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of Society for Mucosal Immunology.","name":"copyright","label":"Copyright"}]}}